Udg Healthcare PLC (LON:UDG)‘s stock had its “buy” rating restated by equities researchers at Liberum Capital in a research report issued to clients and investors on Monday. They currently have a GBX 930 ($11.85) target price on the stock. Liberum Capital’s target price indicates a potential upside of 8.45% from the company’s current price.

Several other equities analysts have also issued reports on the stock. Berenberg Bank lowered shares of Udg Healthcare PLC to a “hold” rating and set a GBX 745 ($9.49) price target on the stock. in a report on Monday, May 15th. Peel Hunt lifted their price target on shares of Udg Healthcare PLC from GBX 730 ($9.30) to GBX 830 ($10.57) and gave the stock an “add” rating in a report on Tuesday, May 23rd. Numis Securities Ltd lowered shares of Udg Healthcare PLC to a “hold” rating and set a GBX 730 ($9.30) price target on the stock. in a report on Tuesday, April 4th. Stifel Nicolaus lifted their price target on shares of Udg Healthcare PLC from GBX 620 ($7.90) to GBX 650 ($8.28) and gave the stock a “hold” rating in a report on Tuesday, April 4th. Finally, Jefferies Group LLC lowered shares of Udg Healthcare PLC to a “hold” rating and lifted their price target for the stock from GBX 760 ($9.68) to GBX 785 ($10.00) in a report on Wednesday, May 24th. Five analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of GBX 773.71 ($9.86).

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Shares of Udg Healthcare PLC (UDG) traded down 0.46% on Monday, reaching GBX 857.50. The company had a trading volume of 860,042 shares. The stock’s 50 day moving average is GBX 790.40 and its 200 day moving average is GBX 711.07. Udg Healthcare PLC has a 52 week low of GBX 518.50 and a 52 week high of GBX 861.50. The firm’s market capitalization is GBX 2.12 billion.

The business also recently disclosed a dividend, which will be paid on Tuesday, June 27th. Stockholders of record on Thursday, June 1st will be paid a dividend of $0.04 per share. The ex-dividend date is Thursday, June 1st. This represents a dividend yield of 0.35%.

WARNING: This story was originally published by American Banking News and is owned by of American Banking News. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/06/19/udg-healthcare-plc-udg-earns-buy-rating-from-liberum-capital.html.

In other news, insider Chris Corbin sold 100,000 shares of Udg Healthcare PLC stock in a transaction on Monday, June 5th. The shares were sold at an average price of GBX 813 ($10.36), for a total transaction of £813,000 ($1,035,800.74). Also, insider Jez Moulding acquired 18,000 shares of the stock in a transaction dated Wednesday, May 31st. The shares were bought at an average price of GBX 808 ($10.29) per share, with a total value of £145,440 ($185,297.49).

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.